If pregnant, or breastfeeding, or if you are taking medication, or on medical care, consult your physician prior to use
PlexusDx supports precision-wellness by revealing genetic predispositions in GLP-1 pathways, enabling more personalized conversations about treatment duration, adjustment, and safe cessation protocols with your provider
At the time of this publication, both subcutaneous liraglutide and semaglutide (2.4 mg weekly dose) are TGA approved for chronic weight management in Australia
600mg of Lion's Mane per serving, with an added 100mg of L-Theanine, 250mg of Cognizin Citicoline, 120mg of Omega 3 DHA and 150mcg of Vitamin B12. Combined with our signature liposomal formula for up to 4x higher absorption
epidermidis compound responsible for GLP-1 stimulatory activity To identify the bacterial component responsible for GLP-1 secretion in vitro and for metabolic disease marker modulation in vivo , we performed size fractionation studies on conditioned supernatants of S